Although progress in transplantation has been achieved during the past decade, many patients waiting for organ transplant face death due to a severe shortage of donor organs. This shortage of organs has engendered a heightened interest in the field of xenotransplantation. Organs from swine are viewed as the most promising candidates for transplants into humans. The major barrier for successful xenotransplantation between discordant species is hyperacute rejection. However, progress in the understanding of hypemcute rejection and approaches to abrogate it have made it likely that in the very near future, hyperacute rejection will be overcome. It will then be necessary to define other mechanisms of xenograft rejection mediated by cellular and humoral pathways of the immune system, including the role of porcine endogenous viruses (PERV) in eliciting human immune responses to porcine organs. To accomplish these goals we will: 1) Characterize the unique cross reaction identified between HLA and SLA antigens using HLA allo-antibodies from patients awaiting transplantation. We will purify anti-HLA from natural xenoreactive antibodies and define their reactivity to porcine cells using both complement-dependent cytotoxicity and immunofluorescence assays. Another approach will use SLA allele-transfected human cells as targets. 2) characterize the cellular and molecular changes in porcine aortic endothelial cells (PAEC) brought about by the ligation of SLA molecules by anti-HLA antibodies. Using purified anti-HLA antibodies we will ligate SLA molecules on PAEC, and signaling cascades will be analysed using biochemical and molecular approaches. We will also determine the molecules involved in the signaling by immunoprecipitation. 3) Determine the consequence of PERV infection for the human immune response to porcine xenografts. We will define the PERV derived peptide motifs which are recognized by human CD8+ T cells in the context of SLA molecules. These studies will be done by pulsing SLA transfected human cells with synthetic nanomer peptides derived from PERV. We will also determine whether human CD8+ T cells can be generated against PERV infected human cells. We will also determine whether PERV infection of human cells results in stable integration of the viral genome in host chromosome by RELAP and real time PCR of PERV infected cells, whether PERV integrase can catalyze the integration by in vitro end nuclease and integration assays and study the effect of this integration on activation of human T lymphocytes by analyzing activation markers by flow cytometry and analyzing the cytokine secretion pattern by ELISPOT. These studies will not only define the role of PERV in eliciting immune responses against xenografts but also towards autoimmunity. Our long term goals are to develop new approaches to prevent or to treat human anti-porcine xenograft rejection based on our knowledge gained in this project in understanding the immunological mechanisms of human anti-porcine cellular responses.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057796-08
Application #
7046735
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Massicot-Fisher, Judith
Project Start
1998-08-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2008-03-31
Support Year
8
Fiscal Year
2006
Total Cost
$298,809
Indirect Cost
Name
Washington University
Department
Surgery
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ramachandran, Sabarinathan; Jaramillo, Andres; Xu, Xiao-Chun et al. (2004) Human immune responses to porcine endogenous retrovirus-derived peptides presented naturally in the context of porcine and human major histocompatibility complex class I molecules: implications in xenotransplantation of porcine organs. Transplantation 77:1580-8
McKane, Brice W; Ramachandran, Sabarinathan; Xu, Xiao-Chun et al. (2004) Natural antibodies prevent in vivo transmission of porcine islet-derived endogenous retrovirus to human cells. Cell Transplant 13:137-43
McKane, Brice W; Ramachandran, Sabarinathan; Yang, Junbao et al. (2003) Xenoreactive anti-Galalpha(1,3)Gal antibodies prevent porcine endogenous retrovirus infection of human in vivo. Hum Immunol 64:708-17
Xu, Xiao-Chun; Goodman, Jeremy; Sasaki, Hitomi et al. (2002) Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am J Transplant 2:314-22
Manna, Partha Pratim; Steward, Nancy; Lowell, Jeffrey et al. (2002) Differentiation and functional maturation of human CD14(+) adherent peripheral blood monocytes by xenogeneic endothelial cells: up-regulation of costimulation, cytokine generation, and toll-like receptors. Transplantation 74:243-52
Manna, P P; Duffy, B; Olack, B et al. (2001) Activation of human dendritic cells by porcine aortic endothelial cells: transactivation of naive T cells through costimulation and cytokine generation. Transplantation 72:1563-71
Xu, X C; Howard, T; Mohanakumar, T (2001) Tissue-specific peptides influence human T cell repertoire to porcine xenoantigens. Transplantation 72:1205-12
Smith, C R; Jaramillo, A; Liu, W et al. (2001) CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts. Transplantation 71:1640-8
Swanson, C J; Olack, B J; Goodnight, D et al. (2001) Improved methods for the isolation and purification of porcine islets. Hum Immunol 62:739-49
Olack, B J; Jaramillo, A; Zhang, L et al. (2001) The role of indirect antigen recognition in islet xenograft rejection. Transplant Proc 33:784-5

Showing the most recent 10 out of 19 publications